Riskpilot← Back to searchSign inGet full accessDentMan AB
ABActiveOrg 5562002989Tranebergsvägen 21Wholesale of pharmaceutical and medical goods · NACE 4646Est. 19791-4 employees
Revenue 2024
SEK 13,3M
-6% vs 2023
EBITDA margin
2.5%
-76% vs 2023
Equity ratio
48.0%
Financial strength
Net profit 2024
SEK 87K
-89% vs 2023
| Revenue | SEK 13,3M | -6% |
| EBITDA | SEK 337K | -76% |
| Net profit | SEK 87K | -89% |
| Total assets | SEK 5,7M | -13% |
| Equity | SEK 2,7M | -16% |
| Employees | — | — |
Legal name
DentMan AB
Org number
5562002989
Legal form
Aktiebolag
NACE code
4646 · Wholesale of pharmaceutical and medical goods
Founded
30 maj 1979
Share capital
SEK 100 000
Employees
1-4
VAT registered
Yes
Audit selected
No
Last report
2024-12-31
Financial year
January – December
Signatory rights
Firman tecknas var för sig av ledamoten suppleanten
Company purpose
Bolaget skall importera och vidareförsälja produkter till tandläkare samt idka agentverksamhet avseende de nordiska länderna liksom anordna kursverksamhet för tandläkare, ävensom idka därmed förenlig verksamhet.
Address
Tranebergsvägen 21
Email
dentman@dentman.se
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Revenue | 10 370 | 12 528 | 12 025 | 14 241 | 13 332 |
| Staff expenses | — | — | — | — | — |
| EBITDA | 1 172 | 1 814 | 475 | 1 407 | 337 |
| Depreciation & amort. | −38 | −0 | −0 | −0 | −0 |
| EBIT | 1 134 | 1 814 | 475 | 1 407 | 337 |
| Net financials | −57 | −30 | −20 | −27 | −4 |
| Profit before tax | 733 | 1 312 | 358 | 1 094 | 183 |
| Tax | −222 | −305 | −113 | −272 | −96 |
| Net profit | 511 | 1 007 | 245 | 822 | 87 |
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Total assets | 4 177 | 5 121 | 5 207 | 6 535 | 5 664 |
| Equity | 1 635 | 2 643 | 2 652 | 3 239 | 2 716 |
| Long-term debt | 0 | 0 | 0 | 0 | 0 |
| Short-term debt | 1 964 | 1 428 | 1 407 | 1 862 | 1 364 |
| Total debt | 1 964 | 1 428 | 1 407 | 1 862 | 1 364 |
EBITDA margin
2.5%
This company
15.8%
Market median
-84% vs market
20202024
Equity ratio
48.0%
This company
38.2%
Market median
+26% vs market
20202024
Return on equity
3.2%
This company
18.4%
Market median
-83% vs market
20202024
Net profit margin
0.7%
This company
8.1%
Market median
-91% vs market
20202024
Asset turnover
2.35×
This company
1.12×
Market median
+110% vs market
20202024
Debt / equity
1.09×
This company
0.62×
Market median
-76% vs market
20202024
- Annual report 2024Filed via Bolagsverket / SCB · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Bolagsverket / SCB · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Bolagsverket / SCB · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Bolagsverket / SCB · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via Bolagsverket / SCB · Period 2020-01-01 – 2020-12-31
| Name | Role | Member since |
|---|---|---|
| Current (3) | ||
| Audit | 2024 | |
LJ Chief Executive Officer | Chief Executive Officer | 2024 |
SO Deputy Chief Executive Officer | Deputy Chief Executive Officer | 2024 |
| Former (1) | ||
KS Audit | Audit | 2022 – 2024 |
No data on file.
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of DentMan AB also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Karl Stefan Mattsson | Audit | 0 companies |
| Daniel Jonathan Jia Ming Bohlin | Audit | 0 companies |
| Lena Jelena Lagerstedt | Chief Executive Officer | 0 companies |
| Sten Olof Lagerstedt | Deputy Chief Executive Officer | 0 companies |